Home » Topics » Conferences

Conferences
RSS

Schering-Plough develops potent farnesyltransferase inhibitor

April 30, 1997

Vertex designs potent, conformationally restricted HIV protease inhibitors

April 30, 1997

Abbott discovers potent topical immunosuppressant with minimal systemic effects

April 30, 1997

Preclinical studies with GPI-2A reported by Genesys Pharma

April 30, 1997

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

ISIS-5320: preclinical study results

April 30, 1997

BMS-200475: profile of a novel anti-hepatitis B compound

April 30, 1997

Didox/Trimidox demonstrate antiretroviral activity in murine model

April 30, 1997

Preclinical results of IL-12 for chronic viral disease

April 30, 1997

Neuraminidase inhibitors highlighted at antiviral conference

April 29, 1997

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...